funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
HQ address
945 Princess St., Kingston, K7L 3N6, CAN
Analytics 4 Life (A4L) has developed a proprietary signal processing and artificial intelligence platform, Agilytics™, to produce machine-learned solutions for the purposes of detecting disease. Agilytics works by mathematically deciphering critical patterns and relationships from billions of captured data points paired with clinical results. By applying this platform to cardiac Phase Space Tomography Analysis (cPSTA) data and paired coronary angiography results, A4L has developed CorVista™, its initial product focused on coronary artery disease (CAD). CorVista aims to non-invasively assess the presence of significant CAD in a single office visit without radiation, exercise, or pharmacological stressors using physiologic signals naturally emitted by the body. Beyond CAD, A4L has begun applying Agilytics to expand CorVista into other cardiac conditions as well as to engineer new products to address disease states in neurology and oncology.

Investigational Device – CorVista is currently under clinical investigation and is not available for commercial distribution.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats